APA (7th ed.) Citation

F, M., M, D., S, K., M, T., M, M., L, S., . . . O, F. (2025). Spiroindoline quinazolinedione derivatives as inhibitors of P-glycoprotein: Potential agents for overcoming multidrug resistance in cancer therapy. Molecular diversity, 29(6), 6519. https://doi.org/10.1007/s11030-025-11150-5

Chicago Style (17th ed.) Citation

F, Moosavi, Divar M, Khabnadideh S, Tavakkoli M, Mohabbati M, Saso L, Poustforoosh A, and Firuzi O. "Spiroindoline Quinazolinedione Derivatives as Inhibitors of P-glycoprotein: Potential Agents for Overcoming Multidrug Resistance in Cancer Therapy." Molecular Diversity 29, no. 6 (2025): 6519. https://doi.org/10.1007/s11030-025-11150-5.

MLA (9th ed.) Citation

F, Moosavi, et al. "Spiroindoline Quinazolinedione Derivatives as Inhibitors of P-glycoprotein: Potential Agents for Overcoming Multidrug Resistance in Cancer Therapy." Molecular Diversity, vol. 29, no. 6, 2025, p. 6519, https://doi.org/10.1007/s11030-025-11150-5.